Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
10/05/2022 04:30 PM EDT Business Wire LadRx Corporation Announces OTCQB Ticker Change to LADX
09/23/2022 09:00 AM EDT Business Wire CytRx Corporation Relaunches as LadRx Corporation
09/07/2022 09:00 AM EDT Business Wire European Patent Office Awards CytRx Key Patent
08/09/2022 08:00 AM EDT Business Wire CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors
05/19/2022 04:30 PM EDT Business Wire CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock
05/17/2022 08:00 AM EDT Business Wire CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.
04/20/2022 08:00 AM EDT Business Wire CytRx Partners with Oncology Development Expert to Advance LADR Platform
03/21/2022 08:00 AM EDT Business Wire CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
03/09/2022 08:00 AM EST Business Wire CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates
02/24/2022 08:00 AM EST Business Wire CytRx Comments on Orphazyme's Update on European Union Regulatory Review of Arimoclomol in Niemann-Pick Disease Type C
Page

Additional News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
09/23/2022 09:39 AM EDT SeekingAlpha CytRx to rename as LadRx
09/07/2022 10:26 AM EDT SeekingAlpha European patent office awards CytRx patent for LADR platform
03/09/2022 12:24 PM EST SeekingAlpha CytRx to absorb subsidiary Centurion BioPharma; former CEO retires from board
12/28/2021 11:53 AM EST SeekingAlpha ImmunityBio pares gains following aldoxorubicin data in cancer
11/12/2021 08:30 AM EST SeekingAlpha CytRx reports Q3 results
10/14/2021 03:56 PM EDT SeekingAlpha CytRx Corporation (CYTR) Investor Presentation - Slideshow
09/07/2021 07:33 PM EDT SeekingAlpha No More Dark Stocks? Invest In Nanocaps Instead
08/24/2021 09:05 AM EDT SeekingAlpha Orphazyme's arimoclomol shows meaningful treatment effect in late-stage NPC study
07/13/2021 08:36 AM EDT SeekingAlpha CytRx inks securities purchase agreement for $10M
06/22/2021 07:31 AM EDT SeekingAlpha Orphazyme: Game Over, Man
Page